Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-006557

General Counsel sold 4,730 shares at an average $10.91 ($51,598)

  • General Counsel acquired 4,730 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

MOORE JOHN R · General Counsel

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-06 Exercise or conversion : show line 1 in the form +4,730 $1.93 $9,129 7,730 D
2022-09-06 Sale : show line 2 in the form −2,379 $10.83 $25,756 5,351 D
2022-09-06 Sale : show line 3 in the form −2,351 $10.99 $25,842 3,000 D
Open-market sales · 4,730 sh · avg $10.91 · $51,598

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-06 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −4,730 127,727 D
Loading xslF345X03/primarydocument.xml…